481181
Silver(I) sulfadiazine
98%
Sinónimos:
Silver sulfadiazine, Sulfadiazine silver
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula empírica (notación de Hill):
C10H9AgN4O2S
Número CAS:
Peso molecular:
357.14
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
244-834-5
MDL number:
Assay:
98%
Form:
powder
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
assay
98%
form
powder
reaction suitability
core: silver
mp
285 °C (dec.) (lit.)
application(s)
PEM fuel cells
material synthesis precursor
SMILES string
Nc1ccc(cc1)S(=O)(=O)N([Ag])c2ncccn2
InChI
1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1
InChI key
UEJSSZHHYBHCEL-UHFFFAOYSA-N
Application
Silver(I) sulfadiazine (AgSD) is popularly used for treating second-degree burn wounds as it acts as an antimicrobial agent and prevents infections. Silver sulfadiazine-impregnated polyurethane (PU) foam, chitosan/chondroitin sulfate films may be used for wound dressing.
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 2
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Jason Wasiak et al.
The Cochrane database of systematic reviews, 3(3), CD002106-CD002106 (2013-04-02)
An acute burn wound is a complex and evolving injury. Extensive burns produce systemic consequences, in addition to local tissue damage. Treatment of partial thickness burn wounds is directed towards promoting healing and a wide variety of dressings are currently
Ayse Ebru Sakallioglu Abali et al.
Journal of burn care & research : official publication of the American Burn Association, 33(6), e309-e312 (2012-11-13)
As a superstition, homemade decoctions are believed to be beneficial for several diseases. This kind of medical therapy, however, can lead to serious adverse effects. In this report, we present three cases from a single family. Each of the family
Silver sulfadiazine-a new topical therapy for pseudomonas in burns: therapy of pseudomonas infection in burns
Fox CL
Archives of Surgery (Chicago, Ill. : 1960), 96(2), 184-188 (1968)